義翹神州(301047.SZ):擬使用不超39億元閒置自有資金進行現金管理
格隆匯8月23日丨義翹神州(301047.SZ)公佈,公司於2022年8月23日召開第一屆董事會第十七次會議和第一屆監事會第十六次會議,審議通過了《關於使用部分閒置自有資金進行現金管理的議案》,公司擬使用額度不超過39億元的閒置自有資金進行現金管理,用於購買投資期限不超過12個月的銀行或其他金融機構發行的安全性高、流動性好的投資產品或中低風險理財產品(包括但不限於結構性存款、協議存款、國債逆回購等),現金管理有效期自公司股東大會審議通過之日起12個月內,在前述額度和期限範圍內,可循環滾動使用,並同意授權總經理在上述有效期及資金額度內行使該項投資決策並簽署相關合同文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.